News for Kringle Pharma, Inc. (4884.T)

Investment in research and development by pharmaceutical companies is expected to propel the growth of the ALS market as they work to develop new...

Press release 29 December, 2021 Kringle Pharma Strengthens IP Portfolio with the Formulation Patent in Europe Kringle... | December 29, 2021

This is a translation of the original document in Japanese prepared for the convenience of readers outside Japan. The original in Japanese shall prevail in the... | August 20, 2021

/PRNewswire/ -- The